Analysis of tumor infiltrating immune cells in Kaposi sarcoma lesions discovers shifts in macrophage populations.

KSHV RNA-sequencing cibersort

Journal

Global health & medicine
ISSN: 2434-9194
Titre abrégé: Glob Health Med
Pays: Japan
ID NLM: 101771579

Informations de publication

Date de publication:
31 Oct 2024
Historique:
received: 26 06 2024
revised: 13 09 2024
accepted: 17 09 2024
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 1 11 2024
Statut: ppublish

Résumé

Limited information exists about the types of immune cells present in Kaposi sarcoma (KS) lesions, especially in KS in the gastrointestinal tract. Using previously reported RNA-sequencing results from Kaposi sarcoma lesions in skin and gastrointestinal tract with normal matched tissues from the same patients at the same time, we investigated changes in lymphocytes in these tissues. We employed a computational method that determines changes in cell type distributions using KS lesion transcriptome data compared to a reference set of RNA expression patterns of purified immune cells. Since secreted cytokines and chemokines from KSHV-infected cells may influence the microenvironment of Kaposi sarcoma lesions, we performed cytokine profiling of conditioned media from KSHV-infected primary human dermal lymphatic endothelial cells. We also measured how this conditioned media altered the differentiation of macrophages in cell culture assays. These results suggested that factors in conditioned media from KSHV-infected endothelial cells promoted differentiation of a promonocytic cell line to proinflammatory macrophages.

Identifiants

pubmed: 39483448
doi: 10.35772/ghm.2024.01066
pmc: PMC11514630
doi:

Types de publication

Journal Article

Langues

eng

Pagination

310-315

Informations de copyright

2024, National Center for Global Health and Medicine.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to disclose.

Auteurs

Takanobu Tagawa (T)

HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, USA.

Guruswamy Mahesh (G)

HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, USA.

Joseph M Ziegelbauer (JM)

HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, USA.

Classifications MeSH